Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Immunomodulatory EFFECTS of Lenalidomide and Pomalidomide ON INTERACTION of TUMOR and BONE MARROW Accessory CELLS IN MULTIPLE MYELOMA.

Gullu Gorgun, PhD, Elisabetta Calabrese, MD, Teru Hideshima, MD, PhD, Giulia Perrone, MD, Giada Bianchi, MD, Hiroshi Ikeda, MD, PhD, Mala Mani, PhD, Yiguo Hu, MD, PhD, Diana Cristea, MD, Loredana Santo, MD, Yu-Tzu Tai, PhD, Nikhil Munshi, MD, Paul Richardson, MD, Kenneth C. Anderson, MD

Blood (2009) 114 (22): 950.

https://doi.org/10.1182/blood.V114.22.950.950

Published: 2009

Journal Articles

A NOVEL Aurora A Kinase INHIBITOR MLN8237 Induces Cytotoxicity and CELL Cycle Arrest IN MULTIPLE MYELOMA.

Gullu Gorgun, PhD, Elisabetta Calabrese, MD, Teru Hideshima, MD, PhD, Jeffrey Ecsedy, PhD, Giada Bianchi, MD, Mala Mani, PhD, Madhavi Bandi, Hiroshi Ikeda, MD, PhD, Giulia Perrone, MD, Yiguo Hu, MD, PhD, Yu-Tzu Tai, PhD, Mei Zheng, Diana Cristea, MD, Loredana Santo, MD, Daniel R. Carrasco, MD, PhD, Nikhil Munshi, MD, Paul Richardson, MD, Kenneth C. Anderson, MD

Blood (2009) 114 (22): 3830.

https://doi.org/10.1182/blood.V114.22.3830.3830

Published: 2009

Journal Articles

AT9283, a Small Molecule Multi-Targeted Kinase Inhibitor Induces Antimyeloma Activity Via Potent Aurora Kinase and STAT3 Inhibition.

Loredana Santo, M.D., Teru Hideshima, MD., Ph.D., Erik A. Nelson, Ph.D, Diana Cirstea, MD, Madhavi Bandi, Ph.D, Hiroshi Ikeda, MD, PhD, Gullu Gorgun, PhD, Sonia Vallet, MD., Samantha Pozzi, MD, Giulia Perrone, MD, Kishan Patel, Yiguo Hu, Ph.D, Matthew S Squires, Murray Yule, Elisabetta Calabrese, MD., Dharminder Chauhan, Ph.D, Nikhil C. Munshi, Kenneth C. Anderson, MD, Noopur Raje, MD.

Blood (2009) 114 (22): 3833.

https://doi.org/10.1182/blood.V114.22.3833.3833

Published: 2009

Journal Articles

Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.

Giulia Perrone, MD, Elisabetta Calabrese, MD., Teru Hideshima, M.D., Ph.D., Gullu Gorgun, PhD,, Ikeda Hiroshi, Diana Cristea, Loredana Santo, Hu Yiguo, Kenneth C. Anderson, MD

Blood (2009) 114 (22): 2849.

https://doi.org/10.1182/blood.V114.22.2849.2849

Published: 2009

Journal Articles

A Novel Aurora-a Kinase Inhibitor MLN8237 Induces Cytotoxicity and Cell Cycle Arrest in Experimental Multiple Myeloma Models.

Gullu Gorgun, PhD, Elisabetta Calabrese, MD, Mala Mani, PhD, Teru Hideshima, M.D., Ph.D., Hiroshi Ikeda, MD, PhD, Giulia Perrone, MD, Loredana Santo, MD, Diana Cirstea, MD, Simona Blotta, Paul G. Richardson, MD, Jeffrey Ecsedy, Kenneth C. Anderson, MD

Blood (2008) 112 (11): 1719.

https://doi.org/10.1182/blood.V112.11.1719.1719

Published: 2008

Journal Articles

Immunomodulatory Effects of Lenalidomide and Bortezomib on Bone Marrow Stroma Cell and CD4 T Cell Interaction in Multiple Myeloma.

Gullu Gorgun, PhD, Elisabetta Calabrese, MD, Teru Hideshima, Hiroshi Ikeda, Giulia Perrone, Loredana Santo, Diana Cirstea, Paul G Richardson, Kenneth C Anderson

Blood (2008) 112 (11): 1690.

https://doi.org/10.1182/blood.V112.11.1690.1690

Published: 2008

Journal Articles

Melphalan 200 Mg/m 2 (Mel200) Versus Melphalan 100 Mg/m 2 (Mel100) in Newly Diagnosed Myeloma Patients: A Prospective, Randomized Phase III Study

Blood (2008) 112 (11): 3316.

https://doi.org/10.1182/blood.V112.11.3316.3316

Published: 2008

Journal Articles

AT7519, a Novel Small Molecule Multi-Cyclin Dependent Kinase Inhibitor, Induces Apoptosis in Multiple Myeloma VIA GSK3β

Loredana Santo, MD, Sonia Vallet, M.D., Teru Hideshima, M.D., Ph.D., Diana Cirstea, MD, Samantha Pozzi, MD, Nileshwari Vaghela, Hiroshi Ikeda, MD, PhD, Yutaka Okawa, MD, Gullu Gorgun, PhD, Giulia Perrone, MD, Elisabetta Calabrese, MD, Matthew S Squires, Marco Ladetto, MD, Nikhil C. Munshi, MD, Mario Boccadoro, Kenneth C. Anderson, MD, Noopur Raje, MD

Blood (2008) 112 (11): 251.

https://doi.org/10.1182/blood.V112.11.251.251

Published: 2008

Journal Articles

A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m 2 (Mel200) Versus Melphalan 100 mg/m 2 (Mel100) in Newly Diagnosed Myeloma Patients.

Blood (2007) 110 (11): 727.

https://doi.org/10.1182/blood.V110.11.727.727

Published: 2007

Journal Articles

Functional Effects of the Bcl-2/Bcl-xL Inhibitor ABT-737 on Primary Cells from Smoldering Multiple Myeloma.

Maria Rosaria Ricciardi, PhD, Elisabetta Calabrese, MD, Fabiana De Cave, PhD, Sara Santinelli, Paola Bergamo, Samantha Decandia, PhD, Chiara Gregorj, PhD, Vincenzo Federico, MD, Michele Milella, MD, Robert Foa, MD, Agostino Tafuri, MD, Maria Teresa Petrucci, MD

Blood (2007) 110 (11): 4782.

https://doi.org/10.1182/blood.V110.11.4782.4782

Published: 2007

Journal Articles

Chronic Lymphocytic Leukemia (CLL) with Discordance in ZAP-70 Expression and IgVH Mutation Status.

Ilaria Del Giudice, MD, PhD, Emanuela M. Ghia, BS, Stefania M. De Propris, PhD, Marilisa Marinelli, BS, Mauro Nanni, PhD, Francesca Mancini, PhD, Massimo Gentile, MD, Elena Giammartini, MD, Elisabetta Calabrese, MD, Francesca R. Mauro, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 2787.

https://doi.org/10.1182/blood.V108.11.2787.2787

Published: 2006

Journal Articles

Dendritic Cell-Based Immunotherapeutic Strategies in Adult Acute Lymphoid Leukemia Patients Treated with Conventional Therapy or with Imatinib.

Anna Guarini, PhD, Roberta Maggio, BSc, Maria Stefania De Propris, PhD, Nadia Peragine, Monica Messina, Elisabetta Calabrese, MD, Cristina Ariola, BSc, Giovanna Meloni, MD, Antonella Vitale, MD, Robert Foà, MD

Blood (2005) 106 (11): 1835.

https://doi.org/10.1182/blood.V106.11.1835.1835

Published: 2005

Journal Articles

Diagnostic Approach to CD5+/CD23+ Leukemic Non-Hodgkin Lymphomas Lacking Lymphnode Histopathology.

Ilaria Del Giudice, MD, Barbara Anaclerico, MD, Maria Stefania De Propris, PhD, Francesca Mancini, BSc, Edoardo Pescarmona, MD, Luisa Bizzoni, MD, Anna Levi, MD, Elisabetta Calabrese, MD, Stefano Pileri, MD, Agostino Tafuri, MD, Anna Guarini, PhD, Robert Foà, MD

Blood (2005) 106 (11): 4690.

https://doi.org/10.1182/blood.V106.11.4690.4690

Published: 2005

NARROW

Immunomodulatory EFFECTS of Lenalidomide and Pomalidomide ON INTERACTION of TUMOR and BONE MARROW Accessory CELLS IN MULTIPLE MYELOMA.

A NOVEL Aurora A Kinase INHIBITOR MLN8237 Induces Cytotoxicity and CELL Cycle Arrest IN MULTIPLE MYELOMA.

AT9283, a Small Molecule Multi-Targeted Kinase Inhibitor Induces Antimyeloma Activity Via Potent Aurora Kinase and STAT3 Inhibition.

Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.

A Novel Aurora-a Kinase Inhibitor MLN8237 Induces Cytotoxicity and Cell Cycle Arrest in Experimental Multiple Myeloma Models.

Immunomodulatory Effects of Lenalidomide and Bortezomib on Bone Marrow Stroma Cell and CD4 T Cell Interaction in Multiple Myeloma.

Melphalan 200 Mg/m 2 (Mel200) Versus Melphalan 100 Mg/m 2 (Mel100) in Newly Diagnosed Myeloma Patients: A Prospective, Randomized Phase III Study

AT7519, a Novel Small Molecule Multi-Cyclin Dependent Kinase Inhibitor, Induces Apoptosis in Multiple Myeloma VIA GSK3β

A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m 2 (Mel200) Versus Melphalan 100 mg/m 2 (Mel100) in Newly Diagnosed Myeloma Patients.

Functional Effects of the Bcl-2/Bcl-xL Inhibitor ABT-737 on Primary Cells from Smoldering Multiple Myeloma.

Chronic Lymphocytic Leukemia (CLL) with Discordance in ZAP-70 Expression and IgVH Mutation Status.

Dendritic Cell-Based Immunotherapeutic Strategies in Adult Acute Lymphoid Leukemia Patients Treated with Conventional Therapy or with Imatinib.

Diagnostic Approach to CD5+/CD23+ Leukemic Non-Hodgkin Lymphomas Lacking Lymphnode Histopathology.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only